Hikma Pharmaceuticals Overview

  • Founded
  • 1978
Founded
  • Status
  • Public
  • Employees
  • 8,600
Employees
  • Stock Symbol
  • HIK
Stock Symbol
  • Investments
  • 19
  • Share Price
  • $34.75
  • (As of Friday Closing)

Hikma Pharmaceuticals General Information

Description

Founded in the Middle East and with headquarters in London, Hikma manufactures generic and in-licensed pharmaceuticals. The firm operates in three segments: injectables, generics, branded, and other, which comprise most of the company's revenue at about 41%, 33%, and 26%, respectively. About 62%, 33%, and 6% of Hikma's sales are based in the U.S., Middle East, North Africa, and Europe, and Other.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
LON
Primary Office
  • 1 New Burlington Place
  • London W1S 2HR
  • England, United Kingdom
+44 020 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hikma Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$34.75 $35.39 $18.75 - $36.80 $8.16B 230M 568K $2.12

Hikma Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 6,529,219 6,688,814 5,750,556 4,294,666
Revenue 2,292,000 2,207,000 2,070,000 1,936,000
EBITDA 742,000 676,000 470,000 (553,000)
Net Income 513,000 486,000 282,000 (843,000)
Total Assets 3,970,000 3,930,000 3,497,000 3,388,000
Total Debt 927,000 685,000 637,000 777,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hikma Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hikma Pharmaceuticals‘s full profile, request access.

Request a free trial

Hikma Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Founded in the Middle East and with headquarters in London, Hikma manufactures generic and in-licensed pharmaceuticals.
Pharmaceuticals
London, United Kingdom
8,600 As of 2020
00000
000000000 00000

000000 0

rcitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehen
000000000000000
Tokyo, Japan
00000 As of 0000
00000000

000 0000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
000000000000000
Mumbai, India
00000 As of 0000
00.00 0000-00-00
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hikma Pharmaceuticals Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Takeda Pharmaceutical Company Corporation Tokyo, Japan 00000 00000000
000 00000000000000 Corporation Mumbai, India 00000 00000000000
000000 Corporation Maharashtra, India 0000
To view Hikma Pharmaceuticals’s complete competitors history, request access »

Hikma Pharmaceuticals Executive Team (26)

Name Title Board Seat Contact Info
Sigurdur Olafsson Chief Executive Officer & Board Member
Riad Mechlaoui President of Injectables
Khalid Nabilsi Chief Financial Officer
Bassam Kanaan Chief Strategy and Corporate Development Officer
Surendera Tyagi Ph.D Chief Scientific Officer & Global Head, Research & Development
You’re viewing 5 of 26 executive team members. Get the full list »

Hikma Pharmaceuticals Board Members (12)

Name Representing Role Since
000000 0000 Self Board Member 000 0000
0000 0000000000 Hikma Pharmaceuticals Board Member 000 0000
00000 00000000 Hikma Pharmaceuticals Director & Vice Chairman 000 0000
00000000 000 00-00000 Self Board Member 000 0000
0000 000000000 Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Hikma Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hikma Pharmaceuticals Investments & Acquisitions (19)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 (000 02-Jan-2019 000000000000000000 0000.00 Medical Supplies 0000 000000000
000000 00000000000 29-Feb-2016 000000000000000000 00.000 Pharmaceuticals 0000 00000000
0000 000000 000000 08-Sep-2015 000000000000000000 0000 Drug Discovery
000000000000000 00 17-Sep-2014 000000000 00000 00 Buildings and Property 0000 00000000
Bedford Laboratories 15-Jul-2014 Merger/Acquisition 00000 Medical Supplies 0000 00000000
You’re viewing 5 of 19 investments and acquisitions. Get the full list »

Hikma Pharmaceuticals Subsidiaries (4)

Company Name Industry Location Founded
Hikma Ventures Corporate Venture Capital London, United Kingdom 2015
00000000000 Distributors (Healthcare) Gräfelfing, Germany 0000
0000 0000000000000 Acquirer Al Salt, Jordan 0000
0000000000 Pharmaceuticals Casablanca, Morocco 0000
To view Hikma Pharmaceuticals’s complete subsidiaries history, request access »

Hikma Pharmaceuticals Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000000000 00 17-Sep-2014 000000000 00000 00 Completed
  • 00000 000000000000
000 00000 00000000 15-Jul-2014 000000000000000000 00000 Completed
  • 00000 000000000000
Unimark Remedies 15-Apr-2011 Corporate 000.00 Completed
To view Hikma Pharmaceuticals’s complete exits history, request access »